lymphoma, Hodgkin, Y-linked pseudoautosomal

Summary

lymphoma, Hodgkin, Y-linked pseudoautosomal (MONDO:0010762) is a cancer. A subtype of Hodgkins lymphoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• ClinVar variants: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	lymphoma, Hodgkin, Y-linked pseudoautosomal
Mondo ID	MONDO:0010762
MeSH	C564034
OMIM	400021
UMLS	C1839076
MedGen	333246
GARD	0024754
Is cancer (heuristic)	yes

Also known as: lymphoma, Hodgkin, Y-linked pseudoautosomal

Data availability: 1 ClinVar variant.

Disease family

This is a subtype of Hodgkins lymphoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › hematopoietic and lymphoid system neoplasm › hematopoietic and lymphoid cell neoplasm › lymphoid neoplasm › lymphoma › Hodgkins lymphoma › lymphoma, Hodgkin, Y-linked pseudoautosomal

Related subtypes (4): splenic hodgkin lymphoma, classic Hodgkin lymphoma, lymphoma, Hodgkin, X-linked pseudoautosomal, nodular lymphocyte predominant Hodgkin lymphoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

1 retrieved; paginated sample, class counts are floors:

1 likely pathogenic

ClinVar	Variant (HGVS)	Gene	Classification	Review
4532271	NC_000023.11:g.41443588G>C		Likely pathogenic	criteria provided, single submitter

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.